Mercado de diagnóstico de cáncer colorrectal: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00013454
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 213
Buy Now

[Informe de investigación]Se espera que el tamaño del mercado de diagnóstico del cáncer colorrectal crezca de 10.374,68 millones de dólares en 2022 a 16.996,48 millones de dólares en 2028; se estima que registrará una tasa compuesta anual del 8,7 % entre 2023 y 2028.

El mercado de diagnóstico del cáncer colorrectal está segmentado según la modalidad, el usuario final y la geografía. El informe ofrece información y análisis de mercado en profundidad, enfatizando parámetros como impulsores, tendencias, oportunidades y análisis del panorama competitivo de los principales actores del mercado en varias regiones. También incluye análisis del impacto de la pandemia de COVID-19 en las principales regiones.

Perspectivas estratégicas

Perspectivas del mercado

Los lanzamientos de nuevos productos impulsan el colorrectal

Los principales actores del mercado de diagnóstico del cáncer colorrectal fabrican una amplia gama de dispositivos que ayudan a reducir la carga del cáncer colorrectal y otras indicaciones asociadas, como pólipos de colon, enfermedad de Crohn, colitis y síndrome del intestino irritable. En julio de 2022, Salud Digestiva de EE. UU. (USDH), una red de consultorios gastrointestinales (GI) de primer nivel, anunció la comercialización de exámenes de colonoscopia asistidos por IA con la instalación más grande del país de módulos de endoscopia GI Genious Intelligent. Se espera que estos módulos ayuden a los médicos a identificar pólipos potencialmente cancerosos y difíciles de detectar en tiempo real. Con el lanzamiento de este dispositivo, los pacientes del sureste, suroeste y centro de Pensilvania ahora pueden acceder a la colonoscopia asistida por IA con capacidades mejoradas. En septiembre de 2020, Olympus Corporation anunció el lanzamiento de ENDO-AID, una plataforma de vanguardia impulsada por inteligencia artificial (IA). La plataforma incluye la aplicación (app) ENDO-AID CADe, un método endoscópico asistido por computadora para la detección de diferentes afecciones del colon. Esta nueva plataforma de IA permite la visualización en tiempo real de lesiones sospechosas detectadas automáticamente y funciona en combinación con su EVIS X1. Por lo tanto, los frecuentes desarrollos y lanzamientos de nuevos productos impulsan el crecimiento del mercado de diagnóstico de cáncer colorrectal.

Información basada en la modalidad

Según la modalidad, el diagnóstico de cáncer colorrectal El mercado se divide en pruebas basadas en heces y pruebas de imagen. En 2022, el segmento de pruebas de imágenes tuvo una mayor participación en el mercado de diagnóstico del cáncer colorrectal y se prevé que registre una CAGR más alta durante el período de pronóstico. El uso de pruebas de imagen en el diagnóstico del cáncer colorrectal ha evolucionado en los últimos años. Los resultados de las imágenes son fundamentales para la vigilancia, el diagnóstico, la estadificación, la selección del tratamiento y la programación del seguimiento. Las pruebas de imágenes implican observar la estructura del colon y el recto para detectar la presencia de áreas anormales. Los exámenes por imágenes utilizan endoscopios, instrumentos en forma de tubos con una luz y una pequeña cámara de video en su extremo, que se inserta en el recto. Estas pruebas exploran el interior del colon y el recto en busca de áreas anormales que puedan ser cáncer o pólipos. Estas pruebas se utilizan con menos frecuencia que las pruebas en heces, requieren más preparación previa y tienen algunos riesgos asociados, a diferencia de las pruebas en heces. Las pruebas de imágenes se clasifican además en colonoscopia, colonografía por TC, sigmoidoscopia flexible, cápsula endoscópica y otras.

El segmento de colonoscopia tuvo la mayor participación del mercado en 2022. Sin embargo, se espera que la colonografía por TC crezca a un ritmo ritmo más rápido durante el período de pronóstico. La colonografía por TC ayuda en el análisis morfológico de las deformidades de la pared y proporciona la información necesaria para la evaluación preoperatoria de la estadificación T en el cáncer colorrectal. Según las pautas de los Criterios de evaluación de respuesta en tumores sólidos (RECIST), la TC es la modalidad más utilizada para evaluar la respuesta al tratamiento en pacientes con tumores de colon y recto con metástasis. Las ventajas comunes de la colonografía por TC son las siguientes: es rápida y segura, ayuda a visualizar todo el colon y no se requiere sedación para realizar la prueba. Se recomienda realizar esta prueba cada cinco años en pacientes asintomáticos con riesgo medio.

Mercado de Diagnóstico de Cáncer Colorrectal, por Modalidad – 2022-2028

Información basada en el usuario final

Según el usuario final, el mercado de diagnóstico del cáncer colorrectal se segmenta en hospitales, laboratorios de diagnóstico, institutos de investigación del cáncer y otros. El segmento de hospitales representó la mayor participación de mercado en 2022 y se prevé que registre la CAGR más alta durante el período de pronóstico.

Los actores del mercado de diagnóstico de cáncer colorrectal adoptan estrategias orgánicas como el lanzamiento de productos y la expansión para expandir su huella geográfica y carteras de productos y satisfacer las crecientes demandas. Las estrategias de crecimiento inorgánico adoptadas por los actores del mercado les permiten expandir sus negocios y mejorar su presencia geográfica. Además, estas estrategias de crecimiento ayudan a las empresas a fortalecer su clientela y ampliar sus carteras de productos.

  • En diciembre de 2022, Epigenomics otorga la licencia de tecnología de biomarcadores de proteínas para pruebas de cáncer colorrectal en sangre. La empresa ha obtenido la licencia del Centro Oncológico MD Anderson de la Universidad de Texas para ciertos derechos de patente y tecnología sobre biomarcadores asociados con la detección del cáncer colorrectal.
  • En agosto de 2021, Illumina adquirió GRAIL para acelerar el acceso de los pacientes a la vida. Salvando la prueba de detección temprana de múltiples cánceres. El análisis de sangre Galleri de GRAIL detecta 50 cánceres diferentes antes de que sean sintomáticos. La adquisición de GRAIL por parte de Illumina acelerará el acceso y la adopción de esta prueba que salva vidas en todo el mundo.

Perfiles de la empresa

  • Medtronic Plc
  • Illumina Inc
  • Clinical Genomics Technologies Pty Ltd
  • EDP Biotech Corp
  • Epigenomics AG
  • F. Hoffmann-La Roche Ltd
  • Quest Diagnostics Inc
  • Novigenix SA
  • Siemens Healthineers AG
  • Bruker Corp
  • Eiken Chemical Co., Ltd.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the driving factors for the colorectal cancer diagnostics market across the globe?

The factors that are driving growth of the market are increasing prevalence of colorectal cancer and launches of new products.

Which country is dominated the colorectal cancer diagnostics market?

The US holds the largest market share in colorectal cancer diagnostics market. The growth of the market in the country is because in 2022, more than 600,000 surgeries are performed annually in the US to treat colon diseases. According to the American Cancer Society, the 5-year survival rate for localized colon cancer is 91% and for localized rectal cancer is 90%.

Who are the major players in the colorectal cancer diagnostics market?

The colorectal cancer diagnostics market majorly consists of the players such as Medtronic Plc, Illumina Inc, Clinical Genomics Technologies Pty Ltd, EDP Biotech Corp, Epigenomics AG, F Hoffmann-La Roche Ltd, Quest Diagnostics Inc, Novigenix SA, Siemens Healthineers AG, Bruker Corp, and Eiken Chemical Co Ltd.

What is colorectal cancer diagnostics?

Colorectal cancer diagnostics refers to the tools, kits and test performed on an individual to diagnose colorectal cancer in an individual. This involves series of non-invasive and invasive test to confirm the cancer and its stage based on that treatment will be provided to the patient.

Which region is the fastest-growing the colorectal cancer diagnostics market?

Asia Pacific is expected to be the fastest growing region in the colorectal cancer diagnostics market. Asia Pacific registered as the fastest-growing region in the global colorectal cancer diagnostics market. The market in this region is driven due to rising incidences of colorectal cancer, easy access to the diagnosis for colorectal cancer, and proposing guidelines for the procedures. Also, increasing government funding for research activities in colorectal cancer is expected to propel the growth of the market for colorectal cancer diagnostics in Asia Pacific.

Which segment is dominating the colorectal cancer diagnostics market?

The colorectal cancer diagnostics market, based on modality, is bifurcated into imaging tests and stool based tests. In 2022, the imaging tests segment held the larger share and is expected to grow at a CAGR of 8.8% during the forecast period. Screening and imaging play a vital role in the diagnostics of colorectal cancer to understand the extent of tumor-affected area, that act as a major driving factor for the growth of the imaging tests segment.

The List of Companies - Colorectal Cancer Diagnostics Market

  1. Medtronic Plc
  2. Illumina Inc
  3. Clinical Genomics Technologies Pty Ltd
  4. EDP Biotech Corp
  5. Epigenomics AG
  6. F. Hoffmann-La Roche Ltd
  7. Quest Diagnostics Inc
  8. Novigenix SA
  9. Siemens Healthineers AG
  10. Bruker Corp
  11. Eiken Chemical Co., Ltd.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports